Your browser doesn't support javascript.
loading
The elusive BAP1 mutation in pediatric melanocytic tumors.
Moustafa, Danna; Mologousis, Mia A; Duncan, Lyn M; Hawryluk, Elena B.
Afiliação
  • Moustafa D; Harvard Combined Dermatology Residency Training Program, Boston, Massachusetts, USA.
  • Mologousis MA; Harvard Medical School, Boston, Massachusetts, USA.
  • Duncan LM; Tufts University School of Medicine, Boston, Massachusetts, USA.
  • Hawryluk EB; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Pediatr Dermatol ; 2024 Jul 30.
Article em En | MEDLINE | ID: mdl-39076037
ABSTRACT
Cutaneous BAP1-inactivated melanocytomas (BIM) are melanocytic proliferations defined histopathologically by an epithelioid, predominantly dermal melanocytic proliferation with loss of BAP1, and have been largely characterized in adult patients but less well-described in pediatric cohorts. BIM share overlapping histological features with those seen in Spitz nevi; however, unlike Spitz nevi, the majority of BIM carry both BAP1 and BRAFV600E mutations. This study investigated the potential overlap of BIMs with pediatric Spitz nevi by performing immunohistochemical staining of BAP1 and BRAFV600E on pediatric melanocytic tumors with banal Spitz and dermal features. None of the stained tumors in our study exhibited the concurrent BAP1 loss and BRAFV600E positivity that are characteristic of adult BIM, suggesting that this is a low-frequency mutation among banal tumors in the pediatric population.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article